A Comparison of Protein-bound and Large Molecular Weight Uremic Toxin Removals With Novel Super High-flux Dialyzer Between Hemodialysis and High Volume Online HDF Modalities
Launched by CHULALONGKORN UNIVERSITY · Aug 21, 2024
Trial Information
Current as of May 06, 2025
Completed
Keywords
ClinConnect Summary
Other secondary outcomes that the researcher wants to study are
1. The reduction ratio of Beta2microglobulin, kappa and lambda free light chain
2. Serum albumin and dialysate albumin loss
3. Quality of life, muscle mass and nutritional status of the patients
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Chronic hemodialysis patients in King Chulalongkorn Memorial hospital
- • Residual renal function less than 100 ml/day
- Exclusion Criteria:
- • Dialyzer allergy
- • Malnutrition requiring intradialytic parenteral nutrition
- • Cirrhosis child C or decompensated cirrhosis
- • Active uncontrolled infection
- • Active cardiovascular disease
- • Advanced stage malignancy
- • Predicted to be undergone living related kidney transplant within 1 year
About Chulalongkorn University
Chulalongkorn University, one of Thailand's premier academic institutions, is dedicated to advancing medical research and enhancing healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive resources and expertise in various medical fields to conduct rigorous scientific investigations. Chulalongkorn University aims to contribute to global health advancements by fostering a culture of excellence in research, education, and community service, ultimately improving patient care and public health standards.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pathum Wan, Bangkok, Thailand
Patients applied
Trial Officials
Rossanun Shoosanglertwijit
Principal Investigator
Chulalongkorn University
Khajohn Tiranathanagul
Principal Investigator
Chulalongkorn University
Pajaree Chariyavilaskul
Principal Investigator
Chulalongkorn University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported